Cargando…
Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions
AIMS: Virus-infected host cells switch their metabolism to a more glycolytic phenotype, required for new virion synthesis and packaging. Therefore, we investigated the effect and mechanistic action of glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) on virus multiplication in host cells following SARS-...
Autores principales: | Bhatt, Anant Narayan, Kumar, Abhishek, Rai, Yogesh, Kumari, Neeraj, Vedagiri, Dhiviya, Harshan, Krishnan H., Chinnadurai, Vijayakumar, Chandna, Sudhir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847085/ https://www.ncbi.nlm.nih.gov/pubmed/35181310 http://dx.doi.org/10.1016/j.lfs.2022.120411 |
Ejemplares similares
-
2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
por: Bhatt, Anant Narayan, et al.
Publicado: (2022) -
Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma
por: Parveen, Sana, et al.
Publicado: (2017) -
Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential
por: Gupta, Divya, et al.
Publicado: (2021) -
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019) -
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
por: Singh, Saurabh, et al.
Publicado: (2015)